Switch to:
More From Other Websites
CYTRX CORP Files SEC form 8-K, Unregistered Sale of Equity Securities May 27 2016
CYTRX CORP Financials May 19 2016
Mast Sickle Cell Drug Seeks to Defy Long Odds Like Leicester City May 12 2016
CYTRX CORP Files SEC form 8-K, Results of Operations and Financial Condition May 11 2016
CytRx reports 1Q loss May 11 2016
CytRx reports 1Q loss May 11 2016
CytRx Reports First Quarter 2016 Financial Results May 11 2016
CYTRX CORP Files SEC form 10-Q, Quarterly Report May 10 2016
CytRx Bear Thesis Explained: Why Sarcoma Drug Trial Will Fail May 10 2016
CytRx to Present at Joseph Gunnar and Co.'s PIONEERS 2016 Investor Conference Apr 28 2016
CytRx to Present at Joseph Gunnar and Co.'s PIONEERS 2016 Investor Conference Apr 28 2016
CytRx and PRA Health Sciences Receive Gold Awards for Excellence in Clinical Research as the... Apr 25 2016
CytRx and PRA Health Sciences Receive Gold Awards for Excellence in Clinical Research as the... Apr 25 2016
CytRx to Present Updated Aldoxorubicin Clinical Trial Data at the American Society of Clinical... Apr 20 2016
CytRx to Present Updated Aldoxorubicin Clinical Trial Data at the American Society of Clinical... Apr 20 2016
3 Stocks With Catalysts That Could Capitalize on Biotech Momentum Apr 08 2016
ETF’s with exposure to CytRx Corp. : April 5, 2016 Apr 05 2016
CytRx Corp (CYTR) in Focus: Stock Rises 10.2% in Session Apr 05 2016
CytRx Global Pivotal Phase 3 Clinical Trial with Aldoxorubicin Achieves 191 Target Events Triggering... Apr 04 2016
CytRx Global Pivotal Phase 3 Clinical Trial with Aldoxorubicin Achieves 191 Target Events Triggering... Apr 04 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK